Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name PTCSC2
   Synonyms NA
   Region GRCh38_9:97805935-97810008    Sequence
   Ensembl ENSG00000236130
   RefSeq NR_147055
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name thyroid cancer
   ICD-0-3 C73.9  
   Methods RIP, Dual-luciferase reporter assay, RNA pull-down assay etc.
   Sample thyroid cancer tissues, cell lines (KTC1, BCPAP, C643, SW1736, TPC1, FTC133)
   Expression Pattern differential expression
   Function Description

Here we report that PTCSC2 binds myosin-9 (MYH9). In a bidirectional promoter shared by FOXE1 and PTCSC2, MYH9 inhibits the promoter activity in both directions. This inhibition can be reversed by PTCSC2, which acts as a suppressor. RNA knockdown of FOXE1 in primary thyroid cells profoundly interferes with the p53 pathway. We propose that the interaction between the lncRNA, its binding protein MYH9, and the coding gene FOXE1 underlies the predisposition to PTC triggered by rs965513.

   Pubmed ID 28049826
   Year 2017
   Title MYH9 binds to lncRNA gene PTCSC2 and regulates FOXE1 in the 9q22 thyroid cancer risk locus.
   External Links
   Links for  PTCSC2 GenBank       HGNC       lncrnadb       Noncode
   Links for  thyroid cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.